Reports for DABIGATRAN ETEXILATE
Ingredient
DABIGATRAN ETEXILATE
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-DABIGATRAN | 150MG | CAPSULE | Resolved | 2020-04-13 | 2021-01-26 | 111898 |
| APO-DABIGATRAN | 110MG | CAPSULE | Actual shortage | 2025-04-10 | 2025-05-01 | 254858 |
| APO-DABIGATRAN | 110MG | CAPSULE | Resolved | 2024-12-05 | 2025-01-24 | 244888 |
| APO-DABIGATRAN | 110MG | CAPSULE | Resolved | 2024-06-14 | 2024-09-20 | 230561 |
| APO-DABIGATRAN | 110MG | CAPSULE | Resolved | 2024-02-09 | 2024-02-23 | 219152 |
| APO-DABIGATRAN | 110MG | CAPSULE | Resolved | 2022-11-20 | 2023-01-20 | 175318 |
| APO-DABIGATRAN | 110MG | CAPSULE | Resolved | 2019-06-26 | 2022-10-07 | 87509 |
| APO-DABIGATRAN | 75MG | CAPSULE | Resolved | 2024-06-13 | 2024-07-19 | 230477 |
| APO-DABIGATRAN | 75MG | CAPSULE | Resolved | 2020-07-08 | 2020-09-01 | 119756 |
| PRADAXA | 110MG | CAPSULE | Resolved | 2019-11-28 | 2020-01-14 | 99977 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PRADAXA | 110MG | CAPSULE | Discontinued | 2017-12-21 | 2017-12-21 | 34114 |
| PRADAXA | 75MG | CAPSULE | To be discontinued | 2025-04-17 | 2025-04-17 | 255171 |
| PRADAXA | 150MG | CAPSULE | Discontinued | 2017-10-19 | 2017-10-19 | 26385 |
Showing 1 to 3 of 3